AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30735912 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study 30735912 — intervention group
Group type: EXPERIMENTAL
Intervention: Real driving conditions
Number of subjects: 27
Study 30735912 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated driving conditions
Number of subjects: 27
Study 29151382 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport-themed ads ('X Games')
Number of subjects: 2040
Study 29151382 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport-themed ads ('snowboard')
Number of subjects: 2040
Study 29151382 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport-themed ads ('gym')
Number of subjects: 2040
Study 29151382 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2040
Study 29151382 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall exposure to energy drink marketing
Number of subjects: 2040
Study 26901812 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel (0, 1.25, 2.5, 5, or 10 grams daily for 16 weeks)
Number of subjects: 198
Study 26901812 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel with anastrozole (suppressing conversion of androgens to estrogens)
Number of subjects: 198
Study 26901812 — intervention group
Group type: COMPARATOR
Intervention: Placebo for goserelin and testosterone
Number of subjects: 198
Study 25281437 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid preload (6% hydroxyethyl starch 130/0.4 500 mL before spinal anesthesia)
Number of subjects: 210
Study 25281437 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid co-load (Ringer's acetate solution 1000 mL administered rapidly starting with intrathecal injection)
Number of subjects: 210
Study 25281437 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid preload
Number of subjects: 210
Study 25281437 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid co-load
Number of subjects: 210
Study 22458343 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroid injections with local anesthetic
Number of subjects: 400
Study 22458343 — intervention group
Group type: COMPARATOR
Intervention: Epidural injections with local anesthetic alone (Control)
Number of subjects: 400
Study 20147463 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-enriched meal (psyllium, 23.0 g)
Number of subjects: 16
Study 20147463 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein and fiber meal
Number of subjects: 16
Study 20147463 — intervention group
Group type: COMPARATOR
Intervention: Low protein and fiber meal
Number of subjects: 16
Study 20147463 — intervention group
Group type: EXPERIMENTAL
Intervention: Low protein and high soluble fiber meal
Number of subjects: 16
Study 17700298 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM) intervention
Number of subjects: 20
Study 17700298 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment comparison group
Number of subjects: 20
Study 16075898 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 31
Study 16075898 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet (Control)
Number of subjects: 31
Study 12126546 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural 2% lidocaine 10 ml combined with 2.5 microg/ml of fentanyl 30 minutes before skin incision followed by 0.125% ropivacaine and 2 microg/ml fentanyl infusion at 9ml/h to the end of surgery (Group II)
Number of subjects: 75
Study 12126546 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural 2% lidocaine 10 ml combined with 2.5 microg/ml of fentanyl and 0.15 mg/ml of droperidol 30 min before incision followed by 0.125% ropivacaine and 2 microg/ml fentanyl infusion at 9ml/h to the end of surgery (Group III)
Number of subjects: 75
Study 12126546 — intervention group
Group type: COMPARATOR
Intervention: Epidural saline as control (Group I)
Number of subjects: 75
Study 10410825 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of propranolol administered IC into the treated artery during balloon inflations
Number of subjects: 15
Study 10410825 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 15
Study 10410825 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg IC propranolol
Number of subjects: 15
Study 10410825 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 15
Study 7812229 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative therapeutic schemes
Number of subjects: 195
Study 2840293 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial ketanserin
Number of subjects: 10
Study 2840293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31081793 — intervention group
Group type: EXPERIMENTAL
Intervention: Gocovri (amantadine)
Number of subjects: 162
Study 31081793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 30514358 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-acupoint TEAS
Number of subjects: 345
Study 30514358 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-acupoint TEAS
Number of subjects: 345
Study 30514358 — intervention group
Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 345
Study 28027638 — intervention group
Group type: EXPERIMENTAL
Intervention: Completely enriched milk powder
Number of subjects: 104
Study 28027638 — intervention group
Group type: COMPARATOR
Intervention: Iron- and vitamin folic-acid-enriched milk powder
Number of subjects: 104
Study 25056567 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release dexmethylphenidate (d-MPH)
Number of subjects: 65
Study 25056567 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release mixed amphetamine salts (MAS)
Number of subjects: 65
Study 25056567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 22268365 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg
Number of subjects: 52
Study 22268365 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 600 mg
Number of subjects: 52
Study 22268365 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 900 mg
Number of subjects: 52
Study 22268365 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan (high u-KIM1 patients)
Number of subjects: 52
Study 22268365 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 52
Study 19933235 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg/day for five consecutive days
Number of subjects: 27
Study 19933235 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 30 mg/day for five consecutive days
Number of subjects: 27
Study 17681986 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard bowel purgation (Group 1)
Number of subjects: 210
Study 17681986 — intervention group
Group type: COMPARATOR
Intervention: Fasting (Group 2)
Number of subjects: 210
Study 17681986 — intervention group
Group type: COMPARATOR
Intervention: No preparation (Group 3)
Number of subjects: 210
Study 15539438 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ring
Number of subjects: 1030
Study 15539438 — intervention group
Group type: COMPARATOR
Intervention: COC
Number of subjects: 1030
Study 11999639 — intervention group
Group type: EXPERIMENTAL
Intervention: pimobendan (1.25 or 2.5mg twice daily)
Number of subjects: 306
Study 9818595 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interrupted and continuous suturing (ICS)
Number of subjects: 95
Study 9818595 — intervention group
Group type: COMPARATOR
Intervention: Single continuous adjustable suturing (SCAS)
Number of subjects: 95
Study 9818595 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study 7815048 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy mood induction
Number of subjects: 182
Study 7815048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad mood induction
Number of subjects: 182
Study 7815048 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral mood induction
Number of subjects: 182
Study 2511939 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-attenders
Number of subjects: 247
Study 1959 — intervention group
Group type: EXPERIMENTAL
Intervention: Mequitazine (10 mg/24 hrs)
Number of subjects: 115
Study 1959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 1959 — intervention group
Group type: EXPERIMENTAL
Intervention: Mequitazine
Number of subjects: 115
Study 7313613 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 56
Study 7313613 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ppm Methyl Chloride (MeCl)
Number of subjects: 56
Study 7313613 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Diazepam and 200 ppm MeCl
Number of subjects: 56
Study 7313613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 30782795 — intervention group
Group type: EXPERIMENTAL
Intervention: Citizen science trials with crowdsourced data from farmers ranking the performance of three varieties.
Number of subjects: 12409
Study 30782795 — intervention group
Group type: COMPARATOR
Intervention: Previous variety recommendations.
Number of subjects: 12409
Study 27516073 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant dependence
Number of subjects: 131
Study 27516073 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dependence
Number of subjects: 131
Study 25603757 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Feedback (AF)
Number of subjects: 20
Study 25603757 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercises (PT group)
Number of subjects: 20
Study 24457404 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg bid for 6 months
Number of subjects: 73
Study 24457404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg qd for 6 months
Number of subjects: 73
Study 24457404 — intervention group
Group type: COMPARATOR
Intervention: Orlistat 120 mg tid for 6 months
Number of subjects: 73
Study 20880335 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel, 80 mg/m², for 12 cycles (B1) when sensitivity test positive
Number of subjects: 92
Study 20880335 — intervention group
Group type: COMPARATOR
Intervention: Control arm (A): Weekly paclitaxel without sensitivity test
Number of subjects: 92
Study 20880335 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC100 for 4 cycles (B2) when sensitivity test negative
Number of subjects: 92
Study 19302634 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute isovolaemic haemodilution in Group 70 (70 beats/min)
Number of subjects: 40
Study 19302634 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute isovolaemic haemodilution in Group 90 (90 beats/min)
Number of subjects: 40
Study 19302634 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute isovolaemic haemodilution in both groups
Number of subjects: 40
Study 17917525 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 3
Study 15555694 — intervention group
Group type: EXPERIMENTAL
Intervention: Family therapy plus pharmacotherapy
Number of subjects: 92
Study 15555694 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifamily psychoeducational group therapy plus pharmacotherapy
Number of subjects: 92
Study 15555694 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy alone
Number of subjects: 92
Study 11458297 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior transposition of the inferior oblique muscle (ATIO)
Number of subjects: 22
Study 11458297 — intervention group
Group type: COMPARATOR
Intervention: Disinsertion of the inferior oblique muscle (DIO)
Number of subjects: 22
Study 9894374 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine ER 2.5 mg (increased to 5 mg or 10 mg if necessary)
Number of subjects: 535
Study 9894374 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg (increased to 10 mg if necessary)
Number of subjects: 535
Study 7811559 — intervention group
Group type: EXPERIMENTAL
Intervention: 123I‐MIBG imaging
Number of subjects: 23
Study 7811559 — intervention group
Group type: COMPARATOR
Intervention: 123I‐BMIPP imaging
Number of subjects: 23
Study 7811559 — intervention group
Group type: COMPARATOR
Intervention: Echocardiography (%SF)
Number of subjects: 23
Study 7811559 — intervention group
Group type: COMPARATOR
Intervention: Echocardiography (E/A ratio)
Number of subjects: 23
Study 3138303 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprostil (35 micrograms twice daily)
Number of subjects: 313
Study 3138303 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 313
Study 3138303 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 313
Study 30791873 — intervention group
Group type: EXPERIMENTAL
Intervention: Clamping after at least 2 min
Number of subjects: 261
Study 30791873 — intervention group
Group type: COMPARATOR
Intervention: Clamping within 20 s
Number of subjects: 261
Study 28820439 — intervention group
Group type: EXPERIMENTAL
Intervention: Letibotulinum toxin A (Botulax)
Number of subjects: 144
Study 28820439 — intervention group
Group type: COMPARATOR
Intervention: Onabotulinum toxin A (Botox)
Number of subjects: 144
Study 26255474 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (salmon calcitonin added to calcium and calcitriol)
Number of subjects: 138
Study 26255474 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive group (incrementality waist musculi dorsi function exercise added to treatment group)
Number of subjects: 138
Study 26255474 — intervention group
Group type: COMPARATOR
Intervention: Control group (calcium and calcitriol)
Number of subjects: 138
Study 23297680 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS02(D) vaccine
Number of subjects: 340
Study 23297680 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B vaccine (Control)
Number of subjects: 340
Study 21872139 — intervention group
Group type: EXPERIMENTAL
Intervention: CCM (Cardiac Contractility Modulation)
Number of subjects: 428
Study 21872139 — intervention group
Group type: COMPARATOR
Intervention: OMT (Optimal Medical Treatment)
Number of subjects: 428
Study 19465671 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestelle progesterone cream 20 mg
Number of subjects: 223
Study 19465671 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestelle progesterone cream 60 mg, 40 mg, 5 mg
Number of subjects: 223
Study 19465671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 16616450 — intervention group
Group type: EXPERIMENTAL
Intervention: Buddy condition (n=237)
Number of subjects: 563
Study 16616450 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n=326)
Number of subjects: 563
Study 15275942 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalations of 20% carbon dioxide (CO2)‐enriched air
Number of subjects: 87
Study 15275942 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmasked and masked attentional bias indices
Number of subjects: 87
Study 10431474 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual administration of flash liberation tablet
Number of subjects: 12
Study 10431474 — intervention group
Group type: COMPARATOR
Intervention: Sublingual administration of freeze-dried reference tablet (lyoc)
Number of subjects: 12
Study 8755841 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus patients after lower limb amputation
Number of subjects: 246
Study 8755841 — intervention group
Group type: COMPARATOR
Intervention: Normal glucose tolerance patients after lower limb amputation
Number of subjects: 246
Study 8755841 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus patients
Number of subjects: 246
Study 8755841 — intervention group
Group type: COMPARATOR
Intervention: Normal glucose tolerance patients
Number of subjects: 246
Study 1862205 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 0
Study 6553504 — intervention group
Group type: EXPERIMENTAL
Intervention: IV infusions of gamma‐radiation‐sterilized cells of Propionibacterium granulosum strain KP‐45
Number of subjects: 82
Study 6553504 — intervention group
Group type: COMPARATOR
Intervention: Cytostatic drugs only (adriamycin, cyclophosphamide, and 5‐fluorouracil)
Number of subjects: 82
Study 31081899 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 160
Study 31081899 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 160
Study 31081899 — intervention group
Group type: COMPARATOR
Intervention: Both Acupuncture and CBT-I
Number of subjects: 160
Study 30192807 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 147
Study 30192807 — intervention group
Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 147
Study 26817506 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-protein diet (2.4 g · kg(‐1) · d(‐1))
Number of subjects: 40
Study 26817506 — intervention group
Group type: COMPARATOR
Intervention: Lower-protein diet (1.2 g · kg(‐1) · d(‐1))
Number of subjects: 40
Study 26817506 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PRO and CON)
Number of subjects: 40
Study 26817506 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in serum cortisol
Number of subjects: 40
Study 24629431 — intervention group
Group type: EXPERIMENTAL
Intervention: afoxolaner chews administered at a dosage of at least 6.3mg/kg (1×)
Number of subjects: 32
Study 24629431 — intervention group
Group type: EXPERIMENTAL
Intervention: afoxolaner chews administered at a dosage of at least 18.9 mg/kg (3×)
Number of subjects: 32
Study 24629431 — intervention group
Group type: EXPERIMENTAL
Intervention: afoxolaner chews administered at a dosage of at least 31.5mg/kg (5×)
Number of subjects: 32
Study 24629431 — intervention group
Group type: COMPARATOR
Intervention: non‐treated control
Number of subjects: 32
Study 22564336 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (awareness of rhinomanometry scores)
Number of subjects: 60
Study 22564336 — intervention group
Group type: COMPARATOR
Intervention: Group B (unaware of rhinomanometry scores)
Number of subjects: 60
Study 20925931 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention after 12 months follow-up
Number of subjects: 424
Study 20925931 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful aging health education intervention after 12 months follow-up
Number of subjects: 424
Study 20925931 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated version of the LLDI
Number of subjects: 424
Study 20925931 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal subscale of the LLDI
Number of subjects: 424
Study 19079397 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscope
Number of subjects: 251
Study 19079397 — intervention group
Group type: EXPERIMENTAL
Intervention: Loupe
Number of subjects: 251
Study 15959421 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-mydriatic camera
Number of subjects: 784
Study 15959421 — intervention group
Group type: COMPARATOR
Intervention: Dilated eye examination
Number of subjects: 784
Study 12919776 — intervention group
Group type: EXPERIMENTAL
Intervention: TNK/ABCX
Number of subjects: 4304
Study 12919776 — intervention group
Group type: EXPERIMENTAL
Intervention: TNK/ENOX
Number of subjects: 4304
Study 12919776 — intervention group
Group type: COMPARATOR
Intervention: TNK/UH
Number of subjects: 4304
Study 10566718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g i.v. 30 min preintervention
Number of subjects: 141
Study 10566718 — intervention group
Group type: COMPARATOR
Intervention: No study medication (control)
Number of subjects: 141
Study 8738816 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 108
Study 8738816 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 108
Study 1681847 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI‐118551
Number of subjects: 8
Study 1681847 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 8
Study 1681847 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 8
Study 1681847 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol and Propranolol
Number of subjects: 8
Study 1681847 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 8
Study 7049585 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol (400 mg)
Number of subjects: 0
Study 7049585 — intervention group
Group type: COMPARATOR
Intervention: Dextropropoxyphene (65 mg) plus Paracetamol (650 mg)
Number of subjects: 0
Study 30743211 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access (RA)
Number of subjects: 1804
Study 30743211 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral access (FA) by default radial operators
Number of subjects: 1804
Study 30743211 — intervention group
Group type: COMPARATOR
Intervention: Femoral access (FA)
Number of subjects: 1804
Study 27762602 — intervention group
Group type: EXPERIMENTAL
Intervention: Forsus
Number of subjects: 28
Study 27762602 — intervention group
Group type: COMPARATOR
Intervention: Elastics
Number of subjects: 28
Study 27762602 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study 26980844 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured tensioning device (80 N)
Number of subjects: 113
Study 26980844 — intervention group
Group type: COMPARATOR
Intervention: Physician group (conventional tensioning)
Number of subjects: 113
Study 25196020 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin replacing ethambutol for 17 weeks followed by 9 weeks of placebo (isoniazid group)
Number of subjects: 1931
Study 25196020 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin replacing isoniazid for 17 weeks followed by 9 weeks of placebo (ethambutol group)
Number of subjects: 1931
Study 25196020 — intervention group
Group type: COMPARATOR
Intervention: Control regimen: isoniazid, rifampin, pyrazinamide, and ethambutol for 8 weeks, followed by 18 weeks of isoniazid and rifampin
Number of subjects: 1931
Study 25196020 — intervention group
Group type: COMPARATOR
Intervention: Control group (for hazard ratios)
Number of subjects: 1931
Study 25196020 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (isoniazid, ethambutol, control)
Number of subjects: 1931
Study 22467013 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (cytostatic and genotoxic drugs)
Number of subjects: 25
Study 22467013 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonsmoker women)
Number of subjects: 25